JP Morgan Chase
VCYT icon

JP Morgan Chase’s Veracyte VCYT Stock Holding History

JP Morgan Chase’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-25,000
Closed -$135K – 4971
2016
Q1 		$135K Buy
+25,000
New +$148K ﹤0.01% 3694

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase's VCYT Position: Q1 2026 in Review

JP Morgan Chase reduced its Veracyte (VCYT) stake by 4.6% in Q1 2026, selling an estimated $885K and leaving 496,219 shares worth $15.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

JP Morgan Chase first reported a position in VCYT in Q3 2016 and has held it in 38 quarters since. The position peaked at $21.9M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • JP Morgan Chase held 496,219 shares of Veracyte worth $15.1M as of Q1 2026.
  • JP Morgan Chase sold 23,910 Veracyte shares in Q1 2026, an estimated $885K.
  • Veracyte made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2321 holding.
  • JP Morgan Chase first reported a position in Veracyte in Q3 2016 and has held it in 38 quarters since.
  • JP Morgan Chase's Veracyte position peaked at $21.9M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.